A phase 1 study of 131I-CLR1404 in patients with relapsed or refractory advanced solid tumors: dosimetry, biodistribution, pharmacokinetics, and safety.

by Joseph J Grudzinski, Benjamin Titz, Kevin Kozak, William Clarke, Ernest Allen, LisaAnn Trembath, Michael Stabin, John Marshall, Steve Y Cho, Terence Z Wong, Joanne Mortimer, Jamey P Weichert
Published 2014-01-01